Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Pegylated recombinant arginine deiminase

EU orphan designation number: EU/3/14/1409   
Active ingredient: Pegylated recombinant arginine deiminase
Indication: Treatment of malignant mesothelioma
Sponsor: Polaris Pharmaceuticals Ireland Limited
88 Harcourt Street, Dublin 2, D02 DK18, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/01/2015 Orphan designation EMA/OD/076/14 (2015)173 of 15/01/2015
12/07/2017 Change of name and/or address of sponsor
27/03/2019 Transfer of orphan designation EMA/OD/0000004587 (2019)2380 of 25/03/2019